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High glucose induces renal tubular 
epithelial injury via Sirt1/NF-kappaB/microR-29/
Keap1 signal pathway
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Abstract 
Objective: Diabetic nephropathy (DN) is a serious complication that commonly confronted by diabetic patients. A 
common theory for the pathogenesis of this renal dysfunction in diabetes is cell injury, inflammation as well as oxida‑
tive stress. In this content, the detailed molecular mechanism underlying high glucose induced renal tubular epithe‑
lial injury was elaborated.
Methods: An in vivo rat model of diabetes by injecting streptozotocin (STZ) and an in vitro high glucose incubated 
renal tubular epithelial cell (HK‑2) model were used. Expression levels of Keap1, nuclear Nrf2 and p65 were deter‑
mined by western blotting. Level of microR‑29 (miR‑29) was assessed using quantitative RT‑PCR. Combination of p65 
and miR‑29 promotor was assessed using chromatin immunoprecipitation. Keap1 3′‑UTR activity was detected using 
luciferase reporter gene assay. Cell viability was determined using MTT assay.
Results: In diabetic rat, miR‑29 was downregulated and its expression is negatively correlated with both of serum 
creatinine and creatinine clearance. In high glucose incubated HK‑2 cell, deacetylases activity of Sirt1 was attenuated 
that leads to decreased activity of nuclear factor kappa B (NF‑κB). NF‑κB was demonstrated to regulate miR‑29 expres‑
sion by directly binding to its promotor. The data of luciferase assay showed that miR‑29 directly targets to Keap1 
mRNA. While high glucose induced down regulation of miR‑29 contributed to enhancement of Keap1 expression that 
finally reduced Nrf2 content by ubiquitinating Nrf2. Additionally, overexpression of miR‑29 effectively relieved high 
glucose‑reduced cell viability.
Conclusion: High glucose induces renal tubular epithelial injury via Sirt1/NF‑κB/microR‑29/Keap1 signal pathway.
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Background
Diabetes mellitus is a common metabolic disorder which 
is associated with chronic complications such as angi-
opathy, retinopathy, and peripheral neuropathy. It was 
recognized that diabetes also can lead to nephropa-
thy. Since then, studies in experimental models and in 
patients observed structural abnormalities in vascular 
and glomerular [1]. However, tubular cells are proved to 
be primary targets of hyperglycemia which is the major 
cause for renal injury and previous evidence indicated 
that chronic exposure to elevated blood glucose levels 
contributes to the organic pathologic changes in clini-
cal diabetes nephropathy (DN) [2, 3]. Thus searching for 
therapy targets might be benefit for concurrency of DN.
In previous study, high glucose induced inflammatory 
response as well as activated inflammation related signal 
pathway. Sirt1, a class III histone deacetylase, is recog-
nized as an important regulator in many high glucose-
related inflammatory diseases [4]. For example, Sirt1 
activator blunting pro-inflammatory pathways in mice 
fed a high fat, high calorie diet [5]. Especially, Sirt1 and 
its modulation of the acetylation status of the p65 subunit 
of nuclear factor kappa B (NF-κB) play an important role 
in regulating the inflammatory and apoptotic responses 
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in cells or tissues [6]. As an essential nuclear transcrip-
tion factor, NF-κB is commonly activated by wide vari-
ety of cell-tress stimuli including obesity, oxidative stress, 
as well as stimulated by hyperglycemia. Accumulated 
evidence pointed out that NF-κB was upregulated in 
diabetic rat kidneys [7] and its inhibition contributed to 
significant amelioration of DN [8]. Although observa-
tion has showed that master regulator of inflammation 
of NF-κB is essential for pathological process of DN, the 
detailed downstream intracellular signal transduction is 
not yet clear.
MicroRNAs are small non-coding RNAs and func-
tion as a key regulatory that affect protein expression 
by process of post-transcription. Abnormal expression 
levels of microRNAs have been described in DN and 
altered protein expression that influence renal function 
[9]. Among these, miR-29 is observed in diabetic patients 
[10] and also ameliorates hyperglycemia-induced renal 
dysfunction [11]. Mechanisms of alteration of microRNA 
expression focused on controlling transcriptional activ-
ity by transcription factor binding to promotor. Nota-
bly, decreased expression of miR-29 by NF-κB signal has 
been described in cells and tissues [12, 13]. Thus we spec-
ulated that NF-κB/miR-29 axis might be involved in high 
glucose incubated renal cell.
MicroRNAs regulate gene expression via suppressing 
translation or causing mRNA degradation. We attempted 
to figure out the target gene for miR-29. The transcrip-
tion factor Nrf2 (NF-E2–related factor 2) has been postu-
lated to be a key regulator of anti-cell press genes and loss 
of Nrf2 activity leads to alteration of ingredient of urinary 
in streptozotocin (STZ)-induced diabetic mice [14]. The 
controller of Nrf2 activity is Keap1 (Kelch-like ECH–
associated protein), an adaptor protein for Cullin3-based 
ubiquitin E3 ligase by ubiquitination and subsequent 
degradation of Nrf2 [15]. Accumulated evidence revealed 
that Keap1 was controlled by microRNAs, such as miR-
200, miR-141 and miR-28 [16]. We made a prediction of 
the possible binding site in Keap1 3′ UTR by miR-29 and 
this was demonstrated by online bioinformatics analysis 
(data is not shown).
Taken together, in this content, we established in vivo 
rat model of diabetes and in vitro high glucose incubated 
renal tubular cell and investigated the Sirt1/NF-κB/miR-
29/Keap1/Nrf2 signal pathway in process of high glucose 
induced renal tubular injury.
Methods
Animal of model of acute diabetes
Adult male Wistar rats (200–250 g) used for the present 
study were obtained from Experimental Animal Insti-
tute of Soochow University. The animals were housed 
in a controlled environment with standard conditions of 
temperature and humidity. The illumination was kept in 
a cycle of an alternating 12 h light and dark. The animal 
protocols were approved by the animal ethics committee 
of Suzhou University, Suzhou, China (No. 49, 17th Nov 
2000).
Rat model of diabetes was induced by intraperitoneal 
injection of streptozotocin (STZ; 65 mg/kg body weight) 
(Sigma-Aldrich Co., St. Louis, MO, USA) in 0.1  mol/L 
citrate buffer. The rats in normal group were received cit-
rate buffer. The blood glucose was examined on day 3 and 
5 after STZ treatment and successful diabetic model was 
with a standard of rat with greater than 16.7 mM blood 
glucose in both examinations. Serum was collected at 0, 
4, 8, 12, 16  weeks for evaluation of blood index. Renal 
tubular was obtained for detection of miR-29 level.
Sample collection and tissue preparation
During the experimental period, the animals were 
housed individually in metabolic cages due to different 
time periods (0, 4, 8, 12 and 16 weeks). The blood sam-
ples were collected from caudal vein over a separately 
period. Serum was obtained by centrifugation for 5 min 
at 4000 rpm centrifugalization and maintained at −80 °C. 
After blood collection, the rats were sacrificed by using 
local ether anaesthesia. Blood was removed from kid-
ney by rat perfusion with normal saline through ascend-
ing aorta. Then the left kidney was rapidly removed and 
renal tubular was separated for homogenate preparation. 
Nuclear and cytoplasmic fractions were extracted from 
renal tissues using a relevant extract kit (Thermo Fisher 
Scientific, Waltham, MA, USA) following the manufac-
turer’s instructions and were used for following molecu-
lar assays.
Assessment of serum creatinine and BUN
Plasma creatinine (Creatinine Assay Kit; Abcam, USA) 
and BUN (Urea Nitrogen (BUN) Colorimetric Detection 
Kit; Arbor Assays, USA) levels were measured according 
to manufacturer’s instructions.
Cell culture
Renal proximal tubular epithelial cell line, HK-2, was 
obtained from American Type Culture Collection 
(ATCC, USA). The cells were cultured in Dulbecco’s 
Modified Eagle’s Medium (DMEM) containing 2  mM 
l-glutamine, 10  % fetal bovine serum (FBS) (Sigma 
Aldrich, USA) with supplemented with 1  % Penicillin 
(100 units/ml)-Streptomycin (10,000  lg/ml). The cells 
were maintained at condition of 37 °C and 5 % CO2. The 
cells were harvested when cell grown to sub-confluence 
and then cultured for 24  h in a medium containing 
5.5 mmol/L glucose and 1 % FBS before being exposed to 
experimental conditions. For in vitro glucose incubating 
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cell, the cells were divided into four groups. First group 
(Normal Glucose) treated with a low glucose concentra-
tion (5.5 mmol/L) was regarded as control. Cells in high 
glucose groups were supplemented with high concentra-
tions of glucose (15, 30, 45 mM, respectively). The 45 mM 
glucose was chose to investigate the mechanism underly-
ing high glucose induced cell injury. All cells were incu-
bated with glucose for 48 h. To evaluate whether NF-κB 
regulates miR-29 expression in high glucose incubated 
HK-2 cell, the cells were pretreated with BAY11-7082 
(5  μmol/L) (Sigma-Aldrich Co., St. Louis, MO, USA), 
an inhibitor for NF-κB pathway for 2  h before glucose 
treatment.
Deacetylation analysis of Sirt1
Sirt1 acetylation activity detection kit (CY-1151, CycLex, 
Japan) was used in  vitro assay of activity of Sirt1 dea-
cetylation according to manufacturer’s instructions. 
In brief, total protein sample from tissue or cells were 
mixed with reaction containing 50  mmol/L Tris–HCl 
(pH 8.8), 0.5  mmol/L DTT, 0.25  mAU/ml Lysyl endo-
peptidase, 1  μmol/L Trichostatin A, 200  μmol/L NAD 
and 20 μmol/L fluoro-substrate peptide. The mixture was 
incubated for 60 min at 37 °C. Then the reacting solution 
was placed in Fluorescence Microplate (SpectraMax M2, 
USA) and fluorescence intensity was examined in light 
of 340 nm Emission Wavelength and 440 nm Excitation 
Wavelength. The final fluorescence value was normalized 
to protein concentration (fu/μg).
NF‑кB luciferase reporter assay
Cells were cultured in 35  mm dishes for 24  h and then 
were transfected with NF-кB-luciferase reporter plas-
mid (Promega, Madison, WI, USA) using lipofectamine 
2000 (Invitrogen, Carlsbad, CA, USA) according to the 
manufacturers’ protocol. After a period of 6  h transfec-
tion, cells were divided into equivalent aliquots for dif-
ferent experimental treatment and seeded in 24-well 
plates. After 18 h incubation under condition of 37 °C in 
a 5  % CO2 incubator, cells were harvested for following 
glucose stimulation. Relative light units were measured 
using Fujifilm LAS3000 Imaging system. The luciferase 
activities were normalized to total protein contents and 
expressed as the fold increase relative to the activity of 
untreated controls.
Quantitative real‑time RT‑PCR
Next, total RNA was from cells or tissues isolated used 
a phenol–chloroform extraction protocol and the purity 
and concentration of RNAs were evaluated with spec-
trophotometric analysis. RNA was transcribed with 
SuperScript III Reverse Transcriptase (Invitrogen, Carls-
bad, CA, USA) using an oligo dT primer. Quantitative 
RT-PCR was performed on a Bio-Rad SYBR Green PCR 
Master Mix (Bio-Rad, Hercules, Calif., USA). The final 
volume of the PCR reaction mixture was 20 ml that con-
tained 2 ml cDNA, 1 mM of each primer, 10 ml GoTaq 
qPCR Master Mix (Promega), and sterile water up to 
20  ml. Calculated Keap1 mRNA expression levels were 
normalized to the expression levels of GAPDH and 
relative miR-29 level was normalized to U6 of the same 
cDNA sample. Relative quantification of gene expression 
was performed using the 2−ΔΔCt calculations.
Western blotting
Western blotting was used to evaluate nuclear Nrf2 
expression and cytoplasmic p65 subunit of NF-κB and 
Keap1 expression. In Brief, samples were reconstituted in 
sample buffer and denatured by boiling for 5 min. Sam-
ples containing 30 mg protein were loaded on 10 % SDS-
PAGE (Bio-Rad, California, USA). The separated proteins 
were then electrophoretic transferred to polyvinylidene 
fluoride (PVDF) membrane (0.45  mm) (Millipore, Ger-
many). Nonspecific protein was blocked by incubation 
with 5  % nonfat  dry milk in TBS for 2  h. Then mem-
brane was blotted by rabbit polyclonal antibodies against 
acetyl-lysine p65 (1:1000; Thermo Fisher Scientific, USA), 
Keap1 (1:1000; Abcam, USA), GST (1:500; Santa Cruz 
biotechnology, CA, USA), NQO1 (1:500; Santa Cruz bio-
technology, CA, USA) and Nrf2 (1:1000; Abcam, USA) 
for 16 h at 4  °C. β-actin was used as loading control for 
cytoplasmic proteins and α-tubulin was used as loading 
control for nuclear protein. The target protein was rec-
ognized by peroxidase-conjugated secondary antibodies 
(Monoclonal anti-rat IgG- peroxidase antibody; 1:2000, 
Sigma Co., USA) by 2 h incubation at room temperature. 
The bands were presented by reacting with Chemilumi-
nescence (ECL). Relative protein band density was quan-
tified by image J.
Transfection
To achieve alteration of expression of miR-29, cells 
were treated with miR-29 mimic or inhibitor with the 
negative control (NC) of nonsense strand using Lipo-
fectamine (Invitrogen). In brief, cells were seeded in 
35  mm dishes at a density of 106 per dish overnight 
before the transfection. Cells and lipofectamine 2000 
were separately diluted with 50  µl Opti-MEM®. These 
two dilutions were then mixed followed with being 
incubated under condition of 5 % CO2 at 37 °C for 48 h. 
After incubation, the mixed medium was replaced with 
fresh medium and cells were harvest for 48 h of glucose 
stimulation. Finally, cell viability was assessed using 
MTT assay and nuclear extract, whole cell lysate and 
total RNA of cells were separately isolated for molecular 
measurement.
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Ectopic expression of Sirt1 and p65 in HK-2 cells was 
realized through pcDNA-Sirt1 and pcDNA-p65 transfec-
tion, respectively. The sequences of Sirt1 and p65 were 
synthesized and cloned into the pCDNA3.1 (Invitrogen, 
Shanghai, China) vector. The empty pcDNA3.1 vec-
tor was used as a control. The prepared plasmid vector 
(pcDNA-Sirt1, pcDNA-p65 and pCDNA3.1) were trans-
fected into HK-2 cell using Lipofectamine (Invitrogen) 
following the manufacturer’s protocol. Forty-eight hours 
post-transfection, the expression levels of Sirt1 and p65 
were detected by western blotting.
Luciferase reporter gene assay
HK-2 cells were seeded at a density of 2 ×  104 cells in 
96-well plates. One day later, cells were co-transfected 
with pGL4-TK-Luc-Keap1 (0.5 μg) with control of pGL-
SV40 (internal control, 0.018  μg) and miR-29 mimic or 
inhibitor. Forty-eight hours after transfection, cells were 
harvested, lysed, and analyzed for luminescence with the 
dual-luciferase assay system (Promega). Luciferase activ-
ity was normalized to pRL-SV40 activity. Experiments 
were repeated at least three times.
Chip assay
The ChIP assay was carried out to detect the possible 
target miR-29 gene by p65. In brief, cells were cross-
linked with 1 % formaldehyde followed by being broken 
using ultrasonication. Soluble chromatin was collected 
by 10,000g centrifugalization at 4 °C for 10 min and incu-
bated with antibodies against p65 (Santa Cruz Biotech-
nology, Inc.) overnight at 4  °C for immunoprecipitation 
with rabbit IgG as negative control. The immune com-
plex was washed and DNA sample was obtained by Gel 
Extraction Kit (Omega Bio-tek, GA, USA). The recov-
ered DNA was then analyzed by qRT-PCR using primers 
flanking the ARE of the human miR-29 promoter. Results 
were normalized to input controls.
In vitro ubiquitination assay
The procedures for the ubiquitin ligase activity assay 
were performed. Briefly, HK-2 cells were co-transfected 
with plasmids expressing Myc-tagged CUL3, T7-tagged 
KEAP1, and HA-tagged ROC1. Twenty-four hours after 
transfection, cells were lysed and immunoprecipitated 
with an anti-Myc antibody. Myc-CUL3 immunocom-
plexes immobilized on protein A-agarose beads were 
incubated with 1 μg of purified His-FLAG-tagged Nrf2 in 
a ubiquitin ligation reaction mixture (final volume, 30 μl) 
containing 50  mM Tris–HCl (pH 7.4), 5  mM MgCl2, 
2  mM NaF, 10  nM okadaic acid, 2  mM ATP, 0.6  mM 
DTT, 1 μg of His6-tagged ubiquitin, 60 ng of E1 (Boston 
Biochem), and 300 ng of E2-UbcH5c at 37 °C for 1 h. The 
reaction was terminated by boiling for 5  min in a SDS 
sample buffer containing 0.1  M DTT, and the proteins 
were resolved by SDS-PAGE, followed by immunoblot-
ting with an anti-FLAG antibody.
BMDCs cells were pre-cultured in a 100  mm dish for 
24 h. Cells were supplemented with different treatments 
for another 12 h and then lysed with RIPA buffer contain-
ing proteinase inhibitor. The lysates were homogenized 
in an ultrasonicator for 10 s twice and incubated on ice 
for 30  min; the homogenates were then centrifuged 
at 15,000×g for 15  min. The concentration of protein 
extracts was detected by the Bradford method using a 
protein assay kit (Beyotime, China).
Immunoprecipitation and immunoblotting were con-
ducted by conventional methods. In brief, the whole 
cell lysates with 0.5 mg of proteins were pretreated with 
protein A-Sepharose beads for 1  h, cultured with 1  μg 
anti-Keap1 or anti-Nrf2 antibody for 4  h to make Nrf2 
and Keap1 immunoprecipitate. The immunoprecipitated 
complexes were then washed five times with RIPA buffer 
and boiled in SDS sample buffer for 5  min. The immu-
noprecipitation products were run on 8  % SDS-PAGE 
and electrophoretically transferred to a PVDF membrane 
(Bio-Rad, USA). These were then incubated with primary 
antibodies (Cell Signaling, USA) according to the manu-
facturer’s protocol, before being incubated with horse-
radish peroxidase conjugated secondary antibody for 
2 h. The protein was finally detected and imaged using a 
GS800 Densitometer Scanner (Bio-Rad, USA).
Statistical analysis
Results were expressed as mean  ±  standard deviation 
(SD). Analysis of variance (ANOVA) was used for mul-
tiple comparisons among groups followed by Tukey–
Kramer post hoc analysis and student t test was used for 
evaluated difference change between two groups using 
the SPSS 16 statistical software. Results were considered 
significant at p < 0.05. To assess the correlation between 
the serum creatinine or blood urea nitrogen (BUN) and 
serum miR-29 level, the Spearman correlation coefficient 
was used. The relationship was described as the correla-
tion coefficient r and statistical significance was defined 
as P < 0.05.
Results
General measurements in diabetic rats
As shown in Fig. 1a, b, compared with normal rat, levels 
of serum creatinine and blood urea nitrogen (BUN) were 
significantly elevated in diabetic rats at week of 8, 12 and 
16 after STZ treatment. Renal tubule was obtained from 
rats treated with STZ for 4, 8, 12, 16  weeks and lyzed 
for analysis of miR-29 expression. The data showed that 
miR-29 level was decreased in time-dependent man-
ner after rat model of diabetes established (Fig. 1c). The 
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correlation analysis demonstrated that abnormal miR-
29 expression is negatively related to serum creatinine 
(Spearman correlation is −0.96, P = 0.000; Fig. 1d) and 
creatinine clearance (Spearman correlation is −0.93, 
P =  0.000; Fig.  1e). These data indicated that miR-29 is 
involved in pathological process of diabetes and might 
Fig. 1 Correlation between blood parameters and signal molecules in diabetic rats. The rat model of diabetes was established by intraperitoneal 
injection of 65 mg/kg STZ. On week 0, 4, 8, 12, 16, a Serum creatinine and b blood urea nitrogen (BUN) were measured, and c renal tubule miR‑29 
level was determined using quantitative RT‑PCR. Correlated analysis was performed to assess relationship between d miR‑29 level and Serum creati‑
nine as well as e miR‑29 level and creatinine clearance. f Sirt1 activity was assessed. g Western blotting was performed to determine expressions of 
Keap1 and nuclear Nrf2 in isolated renal tubules. Data were presented as mean ± SD. **P < 0.01 vs. normal rats
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function as one of modulatory factors. Additionally, we 
also observed that Sirt1 deacetylases activity was attenu-
ated in diabetic rat and declined by the time (Fig.  1f ). 
Diabetic rats expressed higher level of Keap1 and lower 
level of Nuclear Nrf2 in renal tubules (Fig. 1g). Additional 
file  1: Figure S1 presented that diabetic rats were with 
injured renal tubules indicated by vacuolar degeneration 
and extensive loss of brush border.
General measurements in high glucose‑triggered HK‑2 
cells
To investigate the role of miR-29 in injured renal tubule 
of diabetes, the in vitro experimental protocols were per-
formed in high glucose-triggered renal epithelia cell line, 
HK2. Cells were incubated with normal glucose (5.5 mM) 
and high glucose (15, 30, 45 mM) for 48 h and lyzed for 
analysis. We observed that Sirt1 deacetylases activity was 
Fig. 2 Effect of high glucose on renal tubule epithelia cell of HK‑2 in vitro. Cells were triggered with doses of glucose (5.5, 15, 30 and 45) for 48 h. a 
Sirt1 activity was assessed. b NF‑κB transcription activity was evaluated using luciferase reporter gene assay. c miR‑29 expression was determined. 
d Western blot was performed to assess Keap1, GST, NQO1 and nuclear Nrf‑2 expression. e Cell viability was evaluated using MTT assay. Data were 
presented as mean ± S.D. **P < 0.01 vs. cell treated with 5.5 mM glucose
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declined as the increment of high glucose concentra-
tion (Fig.  2a). The transcriptional activity of NF-κB was 
increased with increasing of high glucose concentration 
(Fig.  2b). Level of miR-29 was significantly downregu-
lated in cells incubated with 30 and 45 mM high glucose 
compared with cell treated with 5.5  mM normal glu-
cose (Fig. 2c). In resul t of western blotting, we observed 
that expression of Keap1 was enhanced and expressions 
of GST, NQO1 and nuclear Nrf2 was deceased with 
increasing of glucose concentration (Fig. 2d). Treatment 
of 30 and 40 mM high glucose also substantially reduced 
cell viability (Fig. 2e).
Overexpression of Sirt1 in high glucose‑stimulated HK‑2 
cells
To assess the function of Sirt1 in high glucose-trig-
gered HK-2 cell, we overexpressed the Sirt1 protein 
by pcDNA-Sirt1 transfection and determined the 
Fig. 3 Effect of overexpression of Sirt1 on high glucose‑stimulated HK‑2 cells. Cells were pre‑treated with pcDNA‑Sirt1 with pcDNA as control. 
48 h after incubation, cells were triggered with 5.5 mM and 45 mM glucose for 48 h. a Level of p65 acetylation, b translational activity of NF‑κB and 
c cell viability were determined. Data were presented as mean ± SD. *P < 0.05 vs. cell treated with 5.5 mM glucose, #P < 0.05 vs. cell treated with 
45 mM + pcDNA
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effect of Sirt1 on NF-κB activity and cell viability. The 
45  mM high glucose was chose as final experimental 
concentration. As shown in Fig.  3a, overexpression of 
Sirt1 reversed high glucose-induced increase of acetyl-
p65 expression. By luciferase reporter gene assay, we 
observed that high glucose-induced translational activ-
ity of NF-κB was abrogated by Sirt1 overexpression 
(Fig.  3b). These data suggested that Sirt1 regulating 
NF-κB activity is involved in process of high glucose-
stimulating HK-2 cell. This was further confirmed by 
result of MTT assay which demonstrated that overex-
pression of Sirt1 improved high glucose-reduced cell 
viability while this action was reversed by pcDNA-65 
transfection (Fig. 3c).
NF‑κB binds to miR‑29
Chip assay was performed to assess whether NF-κB 
directly binds to miR-29 gene in high glucose cultured 
HK-2 cell. As shown in Fig.  4a, high glucose promoted 
association between p65 and miR-29 promotor in a man-
ner of time dependent. This data suggested an expres-
sional regulation of miR-29 by NF-κB. This was further 
confirmed by qRT-PCR assay which showed that inhi-
bition of NF-κB pathway by BAY 11-7082 treatment 
increased miR-29 expression in high glucose-triggered 
cell.
MiR‑29 directly regulates Keap1
Detection of abnormal expression of miR-29 and Keap1 
in HK-2 cell lead us to determine whether miR-29 
directly regulates Keap1 expression. We altered miR-
29 expression by cell incubated with miR-29 mimic or 
inhibitor. In HK-2miR−29 mimic cell, level of miR-29 was 
significantly increased by 12.9 fold, binding activity of 
miR-29 and Keap1 promotor was reduced and expression 
of Keap1 mRNA and protein was attenuated compared 
with pre-NC incubated cell (Fig. 5a). The opposite trend 
occurred in HK-2inhbitor cell. As shown in Fig. 5b, level of 
miR-29 declined by 10 fold, binding activity of miR-29 
and Keap1 promotor was boosted that leads to increase 
of the expression of Keap1 mRNA and protein.
High glucose promotes ubiquitination of Nrf2 via miR‑29/
Keap1 axis
To determine the downstream molecule of miR-29/
Keap1 axis, we examined Nrf2, a nuclear transcriptional 
factor that commonly activated by Keap1, in 45  mM 
high glucose-triggered HK-2miR−29 mimic cell. The data 
showed that high glucose promoted ubiquitination of 
Nrf2 whereas this promotion was reversed by overex-
pression of miR-29 (Fig.  6a). By result of western blot-
ting, we observed that high glucose induced upregulation 
of Keap1 and downregulation of nuclear Nrf2 was abro-
gated by miR-29 mimic treatment (Fig. 6b).
Overexpression of miR‑29 enhanced cell viability
To determine the role of miR-29 on high glucose triggered 
cell, cell viability was examined in HK-2miR−29 mimic cell.
As shown in Fig.  7, reduction of cell viability by high 
glucose was effectively enhanced by miR-29 mimic 
treatment.
Discussion
Diabetes mellitus is characteristic of metabolic disor-
ders that contributed to multiple organ or tissue damage 
caused by complex systematic inflammatory and oxidative 
Fig. 4 NF‑κB regulates miR‑29 expression in high glucose‑triggered HK‑2 cells. a Cells were stimulated with 5.5 and 45 mM glucose for 12, 24, 48 h 
and combination of p65 and miR‑29 gene was examined using Chip assay. b Cells were exposed to BAY 11‑7082 for 2 h before 5.5 and 45 mM 
glucose treatment and miR‑29 expression was determined. Data were presented as mean ± S.D. *P < 0.05, **P < 0.01 vs. cell treated with 5.5 mM 
glucose, #P < 0.05 vs. cell treated with 45 mM + DMSO
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stress reactions [1]. At the best studied inflammatory 
mediated factor, NF-κB is rising as an important thera-
peutic target for precaution of diabetes induced kidney 
damage [17]. Thus much attention has been focused on 
the identification of downstream molecules of NF-κB. In 
this present study, we observed that NF-κB activity was 
enhanced mediated by high glucose induced reduction 
of deacetylases activity of Sirt1, which leaded to down-
regulation of miR-29 and inhibition of Keap/Nrf2 signal. 
Notably, both miR-29 and NF-κB activity play vital roles 
in high glucose induced decrease of cell viability. Our 
findings reveal a novel mechanism that modulates patho-
genesis of renal tubular injury in response to high glucose.
Previous study points out that high glucose reduced 
Sirt1 expression that mediated protection against renal 
injury in diabetes [18]. This is also supported by our 
observation that overexpression of Sirt1 significantly 
reduced HK-2 cell viability. As a highly conserved NAD-
dependent deacetylase that target histones, transcription 
factors, co-regulators, Sirt1 regulates adapt gene expres-
sion and metabolism in response to the cellular energy 
state [19]. The important role of Sirt1 in bodies’ activ-
ity is confirmed by a convincing proof which showed is 
a potential therapeutic target of Sirt1 for the treatment 
of the cellular metabolic memory [20]. Presently, accu-
mulated evidence suggests that Sirt1 play a role in basal 
nuclear factor kappa B (NF-κB) repression via controlling 
its transcriptional silencing. Directly association between 
Sirt1 and p65 subunit of NF-kB plays an important role in 
high glucose-triggered human umbilical vein endothelial 
Fig. 5 miR‑29 regulates Keap1 expression in HK‑2 cells. a Cells were transfected with miR‑29 mimic and b miR‑29 inhibitor as well as respective 
negative control (NC) for 48 h; miR‑29 level, translational activity of Keap1 and expression of Keap1 mRNA and protein were determined. Data were 
presented as mean ± S.D. **P < 0.01 vs. pre‑NC or NC
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cells (HUVECs) [21]. Our study was in accordance with 
this previous study by providing evidence in which level 
of acetylated p65 was reduced by overexpression of Sirt1.
NF-κB is composed of a heterodimer of p50 and RelA/
p65 subunits and its transcription factor signaling path-
way is a key mediator of immune response in various 
diseases [22]. In unstimulated cells, NF-κB resides in the 
cytoplasm bound to its inhibitory proteins, which are 
members of the inhibitor of κB (IκB) family. While the 
p65 subunit would be liberated from NF-κB complex to 
translocate to the nucleus in response to stimulation of 
cells by environmental factors, including dietary fatty 
acids. Due to description of decreased expression of miR-
29 by NF-κB signal in cells and tissues [12, 13], we specu-
lated that NF-κB/miR-29 axis might be involved in high 
glucose incubated renal cell. This was demonstrated by 
the data of ChIP which showed a directly targeting miR-
29 promotor by p65 and result of cells incubated NF-κB 
inhibitor, BAY 11-7082 that leaded to abolishment of 
high glucose-induced upregulation of miR-29 expression.
Anti-environmental press pathway serves as an impor-
tant cellular defense against genotoxicity and oxidative 
stress, which has been observed to be closely correlated 
with dysregulation of blood glucose. Recently, the roles 
played by the Keap1-Nrf2 system, a famous anti-envi-
ronmental press pathway, in the pathogenesis of diabetes 
mellitus and in the development of its complications have 
emerged as important research topics. For example, Nrf2 
depletion increases renal oxidative and nitrosative stress in 
the streptozotocin (STZ)-induced mouse diabetes model 
[23]. Pathological analyses revealed that administration of 
Nrf2 inducers, i.e., sulforaphane and cinnamic aldehyde, 
suppressed STZ-mediated diabetic nephropathy [24]. Our 
Fig. 6 Ubiquitination of Nrf2 was regulated by miR‑29/Keap1 axis in high glucose triggered HK‑2 cells. a HK‑2miR−29mimic cells were transfected with 
Flag‑ubiquitin and myc‑Keap1 for 2 h and exposed to 5.5 and 45 mM glucose for 48 h; expression of ubiquitinated Keap1 protein was determined 
using western blot. b Western blot was performed to analyze expression of Keap1 and nuclear Nrf2 in 5.5 mM and 45 mM glucose‑triggered 
HK‑2miR−29mimic cells
Fig. 7 Effect of overexpression of miR‑29 on cell viability in glucose‑
triggered HK‑2 cell. Cells were transfected with miR‑29 mimic and 
exposed to 5.5 and 45 mM glucose; cell viability was examined 
by MTT assay. Data were presented as mean ± S.D. *P < 0.05 vs. 
cell treated with 5.5 mM glucose, #P < 0.05 vs. cell treated with 
45 mM + Pre‑NC
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data revealed that Nrf2 as well as its downstream mol-
ecules GST and NQO1 were downregulated while the 
expression of its regulator, Keap1 was upregulated in high 
glucose incubated HK-2 cell. These findings indicate that 
Nrf2 pathologically and functionally protects the kidney 
against diabetic damage. We next investigated whether 
miR-29 can serve as a regulatory element for Keap1/Nrf2 
system. By luciferase reporter assays and expression analy-
sis of Keap1 in HKmiR−29 mimic or HKmiR−29 inhibitor cells, we 
can draw a conclusion of miR-29 directly regulated Keap1 
expression by targeting Keap1 mRNA 3′ UTR.
Conclusion
In summary, our data suggested that high glucose 
induced renal tubular injury might be a process of a sig-
nal transduction pathway of Sirt1/NF-κB/miR-29/Keap1/
Nrf2. This finding demonstrated a novel mechanism by 
which high glucose causes renal tubules injury and may 
provide insight as to what might be acted as therapy tar-
get by providing evidence supporting a role for miR-29 
overexpression in the inhibition of Keap1/Nrf2 pathway.
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